Target intelligence / Profile preview

Regulatory T cells and effector T cells (Treg/Teff)

Target
Treg/Teff
Molecular classification
Other (Cellular population), Lymphocyte subset
01

Overview

Regulatory T cells (Tregs) and effector T cells (Teffs) are distinct subsets of T lymphocytes that collectively maintain immunological homeostasis and mediate immune responses. Tregs, typically identified by the expression of CD4, CD25, and the master transcription factor Foxp3, function to suppress immune activation and maintain self-tolerance (Sakaguchi et al., 2008, Cell). Conversely, Teffs, which include CD4+ helper cells and CD8+ cytotoxic T cells, are responsible for identifying and eliminating pathogens or malignant cells through the secretion of pro-inflammatory cytokines and direct cytolytic activity (Pardoll, 2012, Nat Rev Cancer). In the context of oncology, an abundance of Tregs within the tumor microenvironment often leads to the suppression of Teffs, allowing for tumor escape from immune surveillance (Facciabene et al., 2012, Cancer Res). Conversely, in autoimmune diseases, a failure in Treg-mediated suppression or an over-activation of Teffs leads to the destruction of healthy tissues. Therapeutic interventions often target the balance between these two populations to restore health. For instance, checkpoint inhibitors like Ipilimumab block CTLA-4 to release Teffs from Treg-mediated inhibition, enhancing anti-tumor immunity (Pardoll, 2012, Nat Rev Cancer). Alternatively, low-dose Interleukin-2 (IL-2) is used to selectively expand Treg populations to treat inflammatory conditions and graft-versus-host disease (Malek, 2008, Annu Rev Immunol). Understanding the interplay between these cells is crucial for developing targeted immunotherapies that can either stimulate or dampen the immune system as needed.

Other names
TregsTeffsT-regulatory cellsT-effector cellsSuppressor T cellsCytotoxic T cellsHelper T cellsCD4+ CD25+ Foxp3+ cellsAntigen-specific T cells
02

Mechanism of action

Therapeutic agents modulate the Treg/Teff ratio by either depleting suppressive Tregs to enhance anti-tumor Teff activity or expanding Tregs to suppress pathogenic Teff activity in autoimmune disorders.

03

Biological functions

Immune responseImmune regulationSelf-toleranceHomeostasisCytokine productionCell-mediated cytotoxicity
04

Disease associations

CancerInflammationAutoimmune diseaseInfectionGraft-versus-host disease
05

Safety considerations

Immune-related adverse events (irAEs)Systemic immunosuppressionCytokine release syndromeLoss of self-toleranceOpportunistic infections
06

Interacting drugs

Aldesleukin

7 more in the full profile.

07

Biomarkers

Foxp3CD25CD127CTLA-4PD-1Ki-67Interferon-gammaIL-10TGF-beta

Beyond the preview

Go deeper on Regulatory T cells and effector T cells (Treg/Teff).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regulatory T cells and effector T cells (Treg/Teff).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call